The future of Lu-177 therapy looks promising, with ongoing research exploring its use in other types of cancer and in combination with other treatments. Clinical trials are underway to evaluate its efficacy and safety in a broader range of cancers, including breast cancer and colorectal cancer. Additionally, advancements in molecular imaging and personalized medicine are likely to enhance the precision and effectiveness of this therapy.